Skip to content

We don't sell Iboga

Iboga .co
  • Home
  • The substance

    The plant Science Safety

    Treatment

    Treatment Legality Compare

    Context

    Tradition Experiences News
  • About
  • Contact
Become a contributor All articles
Treatment

Published 28 August 2026

Ibogaine Therapy Explained

It is called therapy. In the flagship study, no psychotherapy occurred during treatment at all and the experience was completely self-guided.

The word does a lot of work here. In the study that made ibogaine famous, no psychotherapy occurred during treatment: the experience was completely self-guided, participants were spatially separated and wearing eye shades. What surrounds the dose is usually coaching, which the same study says does not involve diagnosing or delving into past traumas.

People search for ibogaine therapy expecting something like psychotherapy with a drug in it. That is not, in general, what is on offer, and the difference is worth knowing before you pay for it.

What the flagship study actually describes

The Nature Medicine veteran study is the most detailed published account of an ibogaine care pathway, and it is unusually precise about this.

During the dosing itself, in its own words, no psychotherapy occurred. The treatment experience was completely self-guided, and patients were spatially separated from each other and wearing eye shades.

Around it, participants were paired with a licensed therapist for structured sessions. Before, that meant intention setting and tools for managing expectations. Afterwards, it meant help processing emotions and integrating insights. And then the sentence that defines the boundary:

Coaching does not involve diagnosing, delving into past traumas or medication-based approaches to healing.

Coaching and therapy are not the same word

That distinction is not pedantry. A licensed therapist doing coaching is operating outside their clinical role by design, and the study says so.

It matters because trauma is the reason most people are there. A service that explicitly does not delve into past traumas is not treating trauma. It is supporting someone through a drug experience, which is a different and narrower thing.

Ibogaine for PTSD covers what that cohort’s results do and do not establish.

The week, as published

The same study gives the only detailed public timetable.

DayWhat happened
1Arrival, blood work, ECG, urinalysis, group preparatory activity
2Further group preparation, an eight-hour fast, dosing in the evening
3The experience
4Integration activities
5Departure

Five days, with a maximum of five patients at once and staffing of at least one person per two patients. On site the wider programme included sweat lodge, massage, yoga, reiki, breathwork and meditation.

What a treatment involves follows the clinical side of that sequence in detail.

Why nobody can tell you which part worked

This is the structural problem and the authors state it plainly. Because the study was not controlled, the relative contribution of any therapeutic benefit from the non-ibogaine elements of the experience, including complementary treatments, group activities, coaching, international travel and expectancy, cannot be determined.

So when a provider tells you their therapeutic programme is what makes their outcomes better, there is no study anywhere that could support that claim, and none that could refute it either.

The wider field has the same gap. A 2026 scoping review of psychosocial protocols in psychedelic-assisted therapy found that what the therapy component consists of is under-specified across the whole field.

What the research says people found useful

There is one piece of real evidence here, and it points at integration rather than at the session.

A mixed-method study of 73 people compared those who did well against those who did not. Responders differed on their ability to tolerate difficult feelings, coping with stress, reduced unhealthy anger, inner peace and openheartedness.

Its conclusion names what was missing, verbatim: notable challenges included psychological and health-related difficulties during treatment and challenges with post-treatment integration, and the findings highlight possible post-treatment needs, meaning more integration and aftercare resources.

A qualitative study of thirteen people who used ibogaine outside any clinic reached a compatible place, locating the benefit in autobiographical memories and personal insights, with preparation, integration and motivation for a lifestyle change named as components.

Four of five authors on the first of those studies were affiliated with the clinic where the participants were treated, and its conflict statement says only that all financial interests have been reported. We note that as we would for any study here.

After treatment covers what the evidence supports doing next.

The word carries a meaning it has not earned

Two things get conflated when a service is called therapy.

Regulatory. No regulator anywhere has approved ibogaine for any condition. Calling something a therapy does not make it an approved one, and no clinic’s use of the word changes that. What the trials found sets out the actual position: nine registered studies, and one published result.

Professional. In a study of 49 psychedelic retreat organisations, 21 worked with at least one licensed health professional, 20 reported one present during at least part of the retreat, and two organisations noted that these professionals could not legally practise under their licences in this context.

That is a specific and useful thing to know. Someone can be a real licensed therapist and still not be acting as one when they are with you.

One finding from that survey to carry into any conversation

Of the 49 organisations, 29 said that facilitators used psychedelics during ceremonies. Seven specified smaller doses and four clarified that someone sober is always present.

That study covered ayahuasca and psilocybin retreats overwhelmingly; only two of the 49 offered ibogaine, so it does not describe the ibogaine sector. It describes the neighbouring one, and it is the only measurement of its kind.

Given that ibogaine’s risk is cardiac and can arrive without warning, whether the person responsible for you is sober is a reasonable question to ask out loud. What emergency preparedness means explains why.

What to ask, if the therapy is the reason you are choosing a provider

  • Is the person supporting me a licensed clinician, and are they acting in that role or as a coach?
  • Are they licensed in the country where the treatment happens?
  • What exactly happens during the dosing itself, and is anyone in the room?
  • How many integration sessions, over how long, and are they included in the price?
  • What happens if I am not better at three months?

That last question matters more than it sounds. The measured effect on drug use across published cohorts is at its maximum at one month and lower afterwards, and the largest follow-up found that seventy per cent of people relapsed. When ibogaine doesn’t work is the part of the story that ends after the integration sessions have finished.

Common questions

In practice it usually means a single dose given in a residential setting, with preparation and integration conversations around it. In the flagship study there was no psychotherapy during the dosing at all.

Often there is a coach rather than a therapist, and the distinction matters. The study that popularised the treatment describes coaching that explicitly does not involve diagnosing or delving into past traumas.

Nobody knows, and no study has been designed to find out. Every published cohort is uncontrolled, so the drug cannot be separated from the coaching, the group, the travel or the expectation.

No regulator anywhere has approved ibogaine for any condition. The word therapy in this context is a description of a service, not a regulatory status.

Often only the vocabulary. The same session can be described as therapy to one audience and as a ceremony to another, and the underlying structure, staffing and monitoring may be identical.

Sources

4 sources · How we source

  1. Magnesium-ibogaine therapy in veterans with traumatic brain injuries

    Primary source · Nature Medicine, 2024 · accessed 28 Aug 2026

  2. Reported Safety Practices of Publicly Advertised Psychedelic Retreats

    Primary source · JAMA Network Open, 2026 · accessed 28 Aug 2026

  3. A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification

    Primary source · Journal of Psychoactive Drugs, 2018 · accessed 28 Aug 2026

  4. Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences

    Primary source · Drug and Alcohol Review, 2023 · accessed 28 Aug 2026

Sources last verified 28 August 2026

Portrait of Kathryn A. Cunningham

Kathryn A. Cunningham

Scientific review 28 August 2026

About

Professor and vice chair of pharmacology and toxicology at the University of Texas Medical Branch, Chauncey Leake Distinguished Professor of Pharmacology, and director of the Center for Addiction Sciences and Therapeutics. A behavioural neuropharmacologist by training, she works on the receptor pharmacology of substance use disorder and on turning that work into candidate treatments, which is the ground the pharmacology and addiction pages on this site stand on. Disclosure: UTMB Health is a partner in the public-university consortium awarded $50 million by the State of Texas in December 2025 to run ibogaine clinical trials, a programme this site covers.

  • Behavioural neuropharmacology
  • Addiction science
  • Serotonin receptor pharmacology
  • Substance use disorder therapeutics

On this page

  • What the flagship study actually describes
  • The week, as published
  • Why nobody can tell you which part worked
  • What the research says people found useful
  • The word carries a meaning it has not earned
  • What to ask, if the therapy is the reason you are choosing a provider

More in Treatment

Browse Treatment
Treatment28 Aug 2026

After Treatment: Integration and Relapse

Treatment28 Aug 2026

Ibogaine Treatment in Canada

Treatment26 Aug 2026

How to Evaluate an Ibogaine Clinic

  1. Home
  2. Treatment
  3. Ibogaine Therapy Explained
Iboga .co

Independent information on iboga and ibogaine: the plant, the science, the risks, the law, and the Bwiti tradition it comes from.

Sections

  • The plant
  • Science
  • Safety
  • Legality
  • Treatment

More sections

  • Tradition
  • Experiences
  • Compare
  • News

About this site

  • The complete guide
  • All articles
  • About
  • Editorial policy
  • Medical review
  • How we source
  • Contributors
  • Contact
iboga.co

© 2026 iboga.co. Independent and unaffiliated.